Renal Dehydropeptidase Inhibitor [EPC] - N0000175514

Pharmacologic Class Information

Pharmacologic Code N0000175514
Pharmacologic Name Renal Dehydropeptidase Inhibitor
Pharmacologic Uses
  • renal dehydropeptidase inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Renal Dehydropeptidase Inhibitor

The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Renal Dehydropeptidase Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-3516Primaxin IVNon-Proprietary Name: Imipenem And Cilastatin SodiumInjection, Powder, For SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
0006-3856Recarbrio Non-Proprietary Name: Imipenem Anhydrous, Cilastatin, And Relebactam AnhydrousInjection, Powder, For SolutionIntravenousMerck Sharp & Dohme LlcACTIVE
44567-705Imipenem And Cilastatin Non-Proprietary Name: Imipenem And CilastatinInjection, Powder, For SolutionIntravenousWg Critical Care, LlcACTIVE
63323-322Imipenem And Cilastatin Non-Proprietary Name: Imipenem And Cilastatin SodiumInjection, Powder, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE
63323-349Imipenem And Cilastatin Non-Proprietary Name: Imipenem And Cilastatin SodiumInjection, Powder, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE